Evidence map›Paper›PMID 32635408›Full record

Trial reportNutrients2020

A Double-Blind, Randomized, Placebo-Controlled Trial of Heat-Killed

Haruka Hishiki, Tadaomi Kawashima, Noriko M Tsuji, Naho Ikari, Ryo Takemura, Hiroshi Kido, Naoki Shimojo

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07479394 (A Double-Blind, Randomized, Placebo-Controlled Trial of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years Old), which is not on this map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07479394 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation

A Double-Blind, Randomized, Placebo-Controlled Trial of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years Old

TypeinterventionalSponsorHasanuddin UniversityRan2026 to 2027Enrolled60ConditionsRespiratory Tract Infections (RTI)Armsa prebiotic, that us a standardized extract of cultured Lentinula edodes mycelia, Placebo (dextrin)
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Probiotics for preventing acute upper respiratory tract infections.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Heat-InactivatedInternational journal of molecular sciences · 2025
    Article
  8. Article
  9. Cancers · 2024
    Article
  10. Diverse impact of a probiotic strain,Bioscience of microbiota, food and health · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Effects of the intake of non-liveBioscience of microbiota, food and health · 2021
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Haruka HishikiDepartment of Pediatrics, Chiba University Hospital, Chiba 260-8670, Japan.
Tadaomi KawashimaResearch and Development Division, Kikkoman Corporation, Chiba 278-0037, Japan.
Noriko M TsujiBiomedical Research Institute, National Institute of Advanced Industrial Science and Technology, Ibaraki 305-0046, Japan.
Naho IkariResearch and Development Division, Kikkoman Corporation, Chiba 278-0037, Japan.
Ryo TakemuraClinical Research Center, Chiba University Hospital, Chiba 260-8677, Japan.
Hiroshi KidoInstitute for Enzyme Research, Tokushima University, Tokushima 770-8503, Japan.
Naoki ShimojoDepartment of Pediatrics, Chiba University Hospital, Chiba 260-8670, Japan.
Kikkoman (Japan) · JPChiba University · JPChiba University Hospital · JPKeio University Hospital · JPNational Institute of Advanced Industrial Science and Technology · JPTokushima University · JP

Funding

Ministry of Education, Culture, Sports, Science and Technology of Japan 19H04042
6 · The paper itself

Abstract

Although some probiotic bacteria have been reported to prevent infections in children, there are few well-designed double-blind studies. Here we evaluated the effects of a probiotic strain of lactic acid bacteria (LAB),

Indexed as

Pediococcus acidilacticiChildChild, PreschoolDouble-Blind MethodFemaleHumansImmunoglobulin A, SecretoryIncidenceInfluenza, HumanMaleProbioticsRespiratory Tract InfectionsSalivaTreatment OutcomeViral ProteinsImmunoglobulin A, SecretoryViral Proteinsdouble-blind studyfebrile daysPediococcus acidilactici K15preschool childrenrespiratory tract infectionssafetysecretory IgA

Identifiers

PMID32635408
PMCPMC7400799
OpenAlexW3039178266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.